Top

International Journal of Colorectal Disease

Published in:

01-04-2006 | Original Article

Echo-enhanced ultrasound—a new imaging modality for the differentiation of pancreatic lesions

Authors: Steffen Rickes, Peter Malfertheiner

Published in: International Journal of Colorectal Disease | Issue 3/2006

Abstract

Introduction

Echo-enhanced ultrasound is a newly available mode of imaging for differential diagnosis of pancreatic tumours. Ductal carcinomas are often hypovascularised compared with the surrounding tissue. Neuroendocrine tumours, on the other hand, are hypervascularised lesions. Tumours associated with pancreatitis have a different vascularisation pattern depending on inflammation and necrosis. Cystadenomas frequently have many vessels along the fibrotic strands.

Results

Data from prospective studies have demonstrated, on the basis of these imaging criteria, that the sensitivity and specificity of echo-enhanced sonography for differentiation of pancreatic masses are ≥85 and ≥90%, respectively.

Conclusions

Pancreatic tumours have a different vascularisation pattern in echo-enhanced ultrasound. These characteristics can be used with high diagnostic accuracy for differential diagnosis.

Hartmann D, Schilling D, Bassler B, Adamek HE, Layer G, Riemann JF (2004) ERCP and MRCP in the differentiation of pancreatic tumors. Dig Dis 22:18–25CrossRefPubMed

Sugiyama M, Atomi Y, Hachiya J (1998) Intraductal papillary tumours of the pancreas. Evaluation with magnetic resonance cholangiopancreatography. Am J Gastroenterol 93:156–159CrossRefPubMed

Hintze RE, Adler A, Veltzke H et al (1997) Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 29:182–187PubMed

Adamek HE, Weitz M, Breer H, Jakobs R, Schilling D, Riemann JF (1997) Value of magnetic-resonance cholangiopancreatography (MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 29:741–744PubMed

Soto JA, Barish MA, Yucel EK, Siegenberg D, Ferrucci JT, Chuttani R (1996) Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology 110:589–597PubMed

Karlson BM, Ekbom A, Lindgren PG et al (1999) Abdominal US for diagnosis of pancreatic tumour: prospective cohort analysis. Radiology 213:107–111PubMed

Palazzo L, Roseau G, Gayet B et al (1993) Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Endoscopy 25:143–150PubMed

Rösch T, Lorenz R, Braig C, Feuerbach S, Siewert JR, Classen M (1990) Endoscopic ultrasound in the diagnosis of pancreatic tumours. Dtsch Med Wochenschr 115:1339–1347PubMed

Rickes S, Unkrodt K, Ocran K et al (2000) Evaluation of Doppler ultrasonography criteria for the differentiation of pancreatic tumours. Ultraschall Med 20:253–258CrossRef

10.

Wermke W, Gaßmann B (1998) Tumour diagnostics of the liver with echo enhancers. Springer Verlag, Berlin Heidelberg New York

11.

Tanaka S, Kitamra T, Fujita M, Yoshioka F (1998) Value of contrast-enhanced color Doppler sonography in diagnosing hepatocellular carcinoma with special attention to the “color-filled pattern”. J Clin Ultrasound 26:207–212CrossRefPubMed

12.

Rickes S, Ocran K, Schulze S, Wermke W (2002) Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis. Ultraschall Med 23:83–90CrossRefPubMed

13.

Rickes S, Schulze S, Neye H, Ocran KW, Wermke W (2003) Improved diagnosing of small hepatocellular carcinomas by echo-enhanced power Doppler sonography in patients with cirrhosis. Eur J Gastroenterol Hepatol 15:893–900CrossRefPubMed

14.

Strobel D, Hoefer A, Martus P, Hahn EG, Becker D (2001) Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions. Int J Colorectal Dis 16:247–256CrossRefPubMed

15.

Rickes S, Ocran KW, Gerstenhauer G, Wermke W (2004) Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound. Dig Dis 22:81–86CrossRefPubMed

16.

Rickes S, Flath B, Unkrodt K et al (2001) Pancreatic metastases of renal cell carcinomas—evaluation of the contrast behaviour at echo-enhanced power Doppler sonography in comparison to primary pancreatic tumours. Z Gastroenterol 39:571–578CrossRefPubMed

17.

Rickes S, Unkrodt K, Neye H, Ocran KW, Wermke W (2002) Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol 37:1313–1320CrossRefPubMed

18.

Rickes S, Unkrodt K, Ocran K, Neye H, Wermke W (2003) Differentiation of neuroendocrine tumours from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy. Pancreas 26:76–81CrossRefPubMed

19.

Ding H, Kudo M, Onda H, Nomura H, Haji S (2001) Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound 29:411–416CrossRefPubMed

20.

Rickes S, Wermke W (2004) Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J Gastroenterol Hepatol 19:761–766CrossRefPubMed

21.

Loperfido A, Angelini G, Benedetti G et al (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1–10PubMed

22.

Bilbao MK, Dotter CT, Lee TG, Katon RM (1976) Complications of endoscopic retrograde cholangiopancreatography (ERCP). Gastroenterology 70:314–320PubMed

23.

Becker D, Strobel D, Bernatik T, Hahn EG (2001) Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 53:784–789CrossRefPubMed

24.

Hocke M, Gottschalk P, Dietrich CF (2004) Ultraschall Med 25(S1): Abstract WS_23_02

25.

Schima W, Fugger R, Schober E et al (2002) Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. Am J Radiol 179:717–724

26.

Papos M, Takacs T, Tron L et al (2002) The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions. Clin Nucl Med 27:197–201CrossRefPubMed

27.

Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206:373–378PubMed

28.

Legman P, Vignans O, Dousser B et al (1998) Pancreatic tumours; comparison of dual-phase helical CT and endoscopic sonography. Am J Radiol 170:1315–1322

29.

Rösch T, Braig C, Gain T et al (1992) Staging of pancreatic and ampullary carcinoma by endoscopic ultrasound. Gastroenterology 102:188–199PubMed

30.

Goldstein HM, Neiman HL, Bookstein JJ (1974) Angiography evaluation of pancreatic disease. A further appraisal. Radiology 112:275–282PubMed

31.

Reuter SR, Redman HC, Bookstein JJ (1970) Differential diagnosis of carcinoma of the pancreas. Radiology 96:93–99PubMed

32.

Appleton GV, Bathurst NC, Virjee J, Cooper MJ, Williamson RC (1989) The value of angiography in the surgical management of pancreatic disease. Ann R Coll Surg Engl 71:92–96PubMed

33.

Koito K, Namieno T, Morita K (1998) Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography. Am J Radiol 170:157–161

34.

Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG (1998) Ultrasound contrast agents. Basic principles. Eur J Radiol 27:157–160CrossRef

35.

Correas JM, Hélénon O, Pourcelot L, Moreau JF (1997) Ultrasound contrast agents. Examples of blood pool agents. Acta Radiol 38:101–112

36.

Kim AY, Choi BI, Kim TK, Kim KW, Lee JY, Han JK (2001) Comparison of contrast-enhanced fundamental imaging, second-harmonic imaging, and pulse-inversion harmonic imaging. Invest Radiol 36:582–588CrossRefPubMed

37.

Rösch T, Lightdale CJ, Botet JF et al (1992) Localisation of pancreatic endocrine tumours by endoscopic ultrasonography. N Engl J Med 326:1721–1726PubMed

38.

Hirota T, Tomida T, Iwasa M, Takahashi K, Kaneda M, Tamaki H (1996) Solitary pancreatic metastasis occurring eight years after nephrectomy for renal cell carcinoma: a case report and review of the literature. Int J Pancreatol 19:145–153PubMed

39.

Thompson LDR, Heffess CS (2000) Renal cell carcinoma to the pancreas in surgical pathology material. A clinicopathological study of 21 cases with a review of the literature. Cancer 89:1076–1088

40.

Rickes S, Unkrodt K, Neye H, Ocran K, Lochs H, Wermke W (2002) Differential diagnosis of frequent pancreatic tumours with echo-enhanced power-Doppler sonography—presentation of case reports. Z Gastroenterol 40:235–240CrossRefPubMed

41.

Ueno E, Takada Y, Yoshida I, Toda J, Sugiura T, Toki F (1998) Pancreatic diseases: evaluation with MR cholangiopancreatography. Pancreas 16:418–426PubMed

42.

Koito K, Namieno T, Ichimura T et al (1998) Mucin-producing tumour of the pancreas: comparison of MR cholangiopancreatography with ER cholangiopancreatography. Radiology 208:231–237PubMed

Title: Echo-enhanced ultrasound—a new imaging modality for the differentiation of pancreatic lesions
Authors: Steffen Rickes
Peter Malfertheiner
Publication date: 01-04-2006
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 3/2006
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-004-0725-y

At a glance: The STEP trials

Springer Medicine

Echo-enhanced ultrasound—a new imaging modality for the differentiation of pancreatic lesions

Abstract

Introduction

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2006

A steroid-refractory ulcerative colitis revealing Epstein–Barr virus/cytomegalovirus-positive colonic lymphoma

Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn’s disease

Late small bowel toxicity after adjuvant treatment for rectal cancer

Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer

Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis

Locally recurrent rectal cancer: when should radiofrequency ablation be used?